Skip to primary navigation
Skip to main content
Join our community
Login
Enter your search
About
Editorial Board
About the Forum
Mission Statement
From the Editors
Expert Commentaries
Videos
Expert Meetings
News
Meeting Reports
Journal Update
Trials
About Trials
ANGPTL3 Inhibitors
ApoCIII Inhibitors
Icosapent Ethyl
SPPARM
View all Trials
Slides
Videos
Back To Basics
About hypertriglyceridaemia
Genetic risk of hypertriglyceridaemia
Triglycerides, triglyceride-rich lipoproteins and remnants
Library
Guidelines
Key Publications
Resources
Forthcoming Meetings
Links
Register
Evinacumab (Evkeeza)
You are here:
Home
> Archives for
ANGPTL3 inhibitors
> Evinacumab (Evkeeza)
Ongoing Trials
Efficacy and safety of evinacumab in paediatric patients with homozygous familial hypercholesterolaemia (NCT04233918)
Long-term efficacy and safety of evinacumab in patients with homozygous familial hypercholesterolaemia (NCT03409744)
Completed Trials
Safety and efficacy of repeat dose evinacumab in patients with severe hypertriglyceridaemia at risk of acute pancreatitis (NCT03452228)
Evinacumab in patients with refractory hypercholesterolaemia (NCT03175367)
ELIPSE
Educational partners and supporters
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.